Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
JAMA Oncology|July 21, 2017
Biosimilars in Oncology in the United States: A ReviewChadi Nabhan, Sandeep Parsad, Anthony R Mato, et al.
Revista Espanola De Anestesiologia Y Reanimacion|January 19, 2024
Intraoperative high flow oxygen therapy for tubeless anaesthesia in thoracoscopic surgeryR Mato-Bua, D Lopez-Lopez, A Garcia-Perez, et al.
Minerva Chirurgica|December 1, 1996
[Laparoscopic surgery in patients over 75 years of age]C Ballesta Lopez, X B Vila, R Mato, et al.
American Journal of Surgery|February 1, 1996
Laparoscopic Billroth II distal subtotal gastrectomy with gastric stump suspension for gastric malignanciesC Ballesta-Lopez, X Bastida-Vila, M Catarci, et al.
PET Clinics|June 21, 2016
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET ImagingEmily C Ayers, Sara Fardin, Saeid Gholami, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many OptionsNitin Jain, Philip Thompson, Alessandra Ferrajoli, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2018
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic LeukemiaErin Bange, Colleen Timlin, Charlene Kabel, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2017
Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative ReviewAnthony R Mato, Meghan C Thompson, Chadi Nabhan, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 3, 2009
Assessment of high-level gentamicin and glycopeptide-resistant Enterococcus faecalis and E. faecium clonal structure in a Portuguese hospital over a 3-year periodR Mato, F Almeida, R Pires, et al.
Cancer Biology & Therapy|March 28, 2018
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapiesAnthony R Mato, Jennifer C Samp, Geneviève Gauthier, et al.
Pageof 12